| Literature DB >> 35662763 |
Sanjay Kalra1,2, Ashok Kumar3, Rakesh Sahay4.
Abstract
Steroid stewardship is the systematic effort to prescribe and monitor glucocorticoids in a rational manner, while balancing benefit and potential risk, in patients who require this therapy. Steroid stewardship includes pre-prescription screening, rational prescription, medical care during corticosteroid use, and appropriate monitoring after corticosteroid use has been discontinued. The current usage of this class of drugs has highlighted the need to focus on this collective responsibility, and ensure effective prescription, while minimizing adverse events. Copyright:Entities:
Keywords: Adrenal; COVID-19; endocrine pharmacology; glucocorticosteroids; iatrogenic Cushing’s; pharmacotherapeutics; pharmacovigilance
Year: 2022 PMID: 35662763 PMCID: PMC9162255 DOI: 10.4103/ijem.ijem_315_21
Source DB: PubMed Journal: Indian J Endocrinol Metab ISSN: 2230-9500
Relative potency of various steroids
| Steroid | Anti-inflammatory effect | HPA Axis suppression | Salt retention |
|---|---|---|---|
| Cortisol | 1 | 1 | 1 |
| Prednisolone | 3 | 4 | 0.75 |
| Methylprednisolone | 6.2 | 4 | 0.75 |
| Dexamethasone | 26 | 17 | 0 |
| Fludrocortisone | 12 | 12 | 125 |
| Triamcinolone | 5 | 4 | 0 |
Table adapted from William’s textbook of Endocrinology 14th ed.. ition. (HPA- Hypothalamo Pituitary Adrenal axis)[7]
Different forms of steroid formulation available for topical, mucosal, and inhalational use
| Formulation type | Clinical usage | Benefits | concerns |
|---|---|---|---|
| Skin | |||
| Ointment | Infiltrated, thick lichenified skin lesions | Occlusive property provides skin hydration | Systemic absorption |
| Cream | Various dermatoses | Ease of application | Systemic absorption |
| Lotion | Various dermatoses | Ease of application | Systemic absorption |
| Gel | Used in various types of skin diseases | Ease of application | Systemic absorption |
| Mucosa | |||
| Eye | Used in inflammatory conditions of eye | Direct delivery | Glaucoma |
| Inhaled steroids | Used in asthma and COPD | Target organ delivery, lesser systemic side effects | Oropharyngeal candidiasis |
Image 135-year-old female on topical steroids, development of striae on one side in axilla at the site of application
Baseline assessment and long-term monitoring of patients planned for long-term systemic corticosteroid therapy
| Baseline clinical examination |
| Weight |
| Height |
| BMI |
| Blood Pressure |
| Acanthosis nigricans/skin tags |
| Pedal edema |
| Baseline Investigations |
| Glucose (FPG, A1C, 2-h OGTT) |
| Lipid Profile |
| DEXA BMD |
| Follow up monitoring |
| Clinical examination - weight gain, BP monitoring. |
| Growth monitoring in children |
| Glucose (FPG, A1C, 2-h OGTT) |
| Lipid Profile |
| Bone Health |
| Assessment of risk of fragility fractures. |
| DEXA BMD |
| X-ray spine |
| change in height (Vertebral fracture) back pain, limping (Avascular Necrosis of Hip). |
| FRAX scoring and risk assessment for vertebral fracture risk. |
| Timely administration of the bisphosphonates other measures to maintain good bone health needs to be ensured. |
| Ophthalmological assessment for cataract and glaucoma |
Steroid Tapering and withdrawal
| Steroid Dose | Duration <3 weeks | Duration >3 weeks |
|---|---|---|
| >7.5 mg Prednisolone | Can stop without tapering | Reduce every 3-4 days to reach a dose of 5 mg per day, thereafter reduce 1 mg every 2-4 weeks. |
| 5-7.5 mg Prednisolone | Can stop without tapering | |
| <5 mg Prednisolone | Can stop without tapering |
Table adapted from William’s textbook of Endocrinology 14th Edition.[7]